Answers are grounded in this paper and cite their sources.
Risk stratification of patients with early stage breast cancer may support adjuvant chemotherapy decision-making. This review details the development and validation of six multi-gene classifiers, each of which claims to provide useful prognostic and possibly predictive information for early stage breast cancer patients. A careful assessment is presented of each test's analytical validity, clinical validity, and clinical utility, as well as the quality of evidence supporting its use.
No takes yet. Share an insight, caveat, or question.
Hyams et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: